Nicola Ambler Jan 23
Top 15 cell and gene therapy biotechs to watch in 2018

Top 15 Cell and Gene Therapy Biotechs to Watch in 2018

We're keeping tabs on all the innovators and disruptors for you in the field of cell and gene therapies

 

The pace of innovation across cell and gene therapy biotechs is gaining speed and it can be challenging to keep track of scientific developments, new technologies and who might be looking for their next big partnership.

The annual ‘Top Cell and Gene Therapy Biotechs to Watch’ e-book examines 15 of the world’s leading cell and gene therapy biotechnology companies, providing you with an at-a-glance view plus more detailed information on how their pipelines are developing. We're impartial so the list in alphabetical order...

...but who is your pick for the most disruptive?

 

  1. Audentes Therapeutics
  2. AVROBIO
  3. Betalin Therapeutics
  4. BlueRock Therapeutics
  5. Homology Medicines
  6. Magenta Therapeutics
  7. MeiraGtX
  8. Mustang Bio
  9. Orchard Therapeutics
  10. Quethera
  11. Semma Therapeutics
  12. T-Knife
  13. Touchlight
  14. TxCell
  15. Vivet Therapeutics

 

View your e-book to find out more.

Top 15 cell and gene therapy biotechs to watch in 2018